- Accueil
- Chercheurs
- Dr Jean-Pierre Déry
Domaine de recherche
Cardiologie Interventionelle; Syndrômes coronariens aigus, thérapie antiplaquettaire, maladie coronarienne athérosclérotique, traitement de la dyslipidémie.
Description des travaux
1- Le projet STEMI est une étude portant sur l'évaluation des délais de traitement des patients souffrant d'un infarctus aigu du myocarde dans la région de Québec et traités par angioplastie primaire à l'Institut universitaire de cardiologie et de pneumologie de Québec. Il s'agit d'une étude régionale faite en collaboration avec les urgences des hôpitaux transférant des patients à l'Institut universitaire de cardiologie et de pneumologie de Québec pour angioplastie soit le Centre Hospitalier de l'Enfant-Jésus, le Centre Hospitalier Chauveau, le Centre Hospitalier Saint-François-d'Assise, le CHUL, le Centre Hospitalier de Portneuf, l'Hôtel-Dieu de Lévis et le Centre Hospitalier du Saint-Sacrement. L'urgence de l'Institut universitaire de cardiologie et de pneumologie de Québec est elle aussi impliquée dans le protocole. Cette étude évaluera le délai de chaque étape du traitement d'un patient se présentant à l'urgence en infarctus du myocarde, et pour qui une angioplastie coronarienne est réalisée en urgence..
Dans le cadre de ce projet, nous évaluons aussi l'évolution des patients en post-infarctus dans le but de comparer les patients s'étant présentés directement à l'Institut universitaire de cardiologie et de pneumologie de Québec avec ceux ayant dû être transférés, ce qui nous permettra de déterminer si le délai supplémentaire que subissent les patients transférés (en moyenne 20 minutes) a un impact sur leur pronostic. Dans le cadre d'une sous-étude de l'étude STEMI, nous nous proposons d'évaluer la corrélation qui existe entre différents polymorphismes génétiques, la non-réponse à une thérapie aux statines et la non atteinte des cibles thérapeutiques des lignes directrices canadiennes chez les patients ayant dû subir une angioplastie primaire pour cause d'infarctus du myocarde avec sus-décalage du segment ST (STEMI). De la même façon, la non-réponse ou la réponse partielle au Clopidogrel sera également étudiée.
2- l'angioplastie coronarienne percutanée (ACP) est fréquemment utilisé pour le traitement de patients souffrant d'angor stable. Toutefois, la littérature actuelle semble suggérer qu'un traitement médical, surtout lorsque associé à un programme de conditionnement physique, serait aussi bon, sinon meilleur, qu'une traitement par ACP. Toutefois, aucune étude n'a comparé le devenir de patients subissant une ACP et soumis à un programme d'exercice physique au devenir de patients suivant seulement le programme d'exercice sans avoir subit l'ACP. Pour clarifier cette question, nous avons débuté l'étude pilote ESCAPE (Exercice Seul ou Combiné à l'Angioplastie coronarienne PErcutanée dans le traitement de patients souffrant d'angor stable).
Prix et distinctions
1- Bourse de formation de 2e cycle (maîtrise) 2003-2004 Fonds de la Recherche en Santé du Québec (FRSQ) - Bourse de perfectionnement Pfizer, 2003 Association des Cardiologues du Québec
Publications
86- Déry JP, Harrington RA, Tcheng JE. GP IIb/IIIa blockade in elective percutaneous coronary intervention.. Curr Pharm Des 2004; 10(4):387-98.
- Déry JP, Braden GA, Lincoff AM, Kereiakes DJ, Browne K, Little T, George BS, Sane DC, Cines DB, Effron MB, Mascelli MA, Langrall MA, Damaraju L, Barnathan ES, Tcheng JE,. Final results of the ReoPro readministration registry.. Am J Cardiol 2004; 93(8):979-84.
- Déry JP, Hernandez AF, Kay JD, Petersen JL, Rao SV, Rebeiz AG, Singh KP, Donahue MP. Highlights from the American Heart Association Annual Scientific Sessions 2003. Am Heart J 2003; 145(3):554-62.
- Déry JP, Gilbert M, O'Hara G, Champagne J, Desaulniers D, Cartier P, Philippon F. Pacemaker contact sensitivity: case report and review of the literature.. Pacing Clin Electrophysiol 2002; 25(5):863-5.
- Déry JP, Patel MR, Shah SH, Meine TJ, Yager J, Lotfi M, Hernandez AF, Peterson JL. Highlights from the American College of Cardiology Annual Scientific Sessions 2003: November 9 to 12, 2003.. Am Heart J 2004; 10(4):387-398.
- Rebeiz Ag, Déry JP, Tsiatis AA, O'Shea JC, Johnson BA, Hellkamp AS, Pieper KS, Gilchrist IC, Slater J, Muhlestein JB, Joseph D, Kitt MM, Tcheng JE. Optimal Duration of Eptifibatide Infusion in Percutaneous Coronary Intervention: an ESPRIT Substudy.. Am J Cardiol 2004; 94(0):926-9.
- Shah SH, Déry JP, Fischi MC, Heitner JF, Kunz GA, Meine TJ, PAtel MR, Valente AM, Waters RE, Yager J. Highlights from the American College of Cardiology Annual Scientific Sessions 2004: March 9-12, 2004.. Am Heart J 2004; 148(2):254-262.
- Petersen JL, Déry JP, Fischi MC, Hernandez AF, Hranitzky PM, Rao SV, Rebeiz AG, Singh KP. Highlights from the American College of cardiology Annual Scientific Sessions 2003: March 28 to April 2, 2003. Am Heart J 2003; 146(1):19-26.
- Déry JP, O'Shea JC, Tcheng JE. Eptifibatide in percutaneous coronary intervention. A review.. Minerva Cardioangiol 2002; 50(5):531-46.
- Kandzari DE, Dery JP, Armstrong PW, Douglas DA, Zettler ME, Hidinger GK, Friesen AD, Harrington RA. MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury.. Expert Opin Investig Drugs 2005; 14(11):1435-42.
- Puma JA, Banko LT, Pieper KS, Sacchi TJ, O'Shea JC, Dery JP, Tcheng JE. Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the enhanced suppression of the platelet IIb/IIIa receptor with integrilin therapy (ESPRIT).. J Am Coll Cardiol 2006; 47(4):715-8.
- Li M, Déry JP, Dumesnil JG, Boudreault JR, Jobin J, Pibarot P. Usefulness of measuring net atrioventricular compliance by Doppler echocardiography in patients with mitral stenosis.. Am J Cardiol 2005; 96(3):432-5.
- Bertrand OF, De Larochellière R, Rodés-Cabau J, Proulx G, Gleeton O, Nguyen CM, Déry JP, Barbeau G, Noël B, Larose E, Poirier P, Roy L. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.. Circulation 2006; 114(24):2636-43.
- Potvin JM, Rodés-Cabau J, Bertrand OF, Gleeton O, Nguyen CN, Barbeau G, Proulx G, De Larochellière R, Déry JP, Batalla N, Dana A, Facta A, Roy L. Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris, non-ST-elevation and ST-elevation acute myocardial infarction, or aty. Am J Cardiol 2006; 98(3):289-97.
- Déry JP, Campbell ME, Mathias J, Pieper KS, Harrington RA, Madan M, Gibson CM, Tolleson TR, O'shea JC, Tcheng JE. Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; Results from the ESPRIT trial.. Catheter Cardiovasc Interv 2007; 70(1):43-50.
- Rodés-Cabau J, Facta A, Larose E, Delarochellière R, Déry JP, Nanh Guyen C, Roy L, Proulx G, Gleeton O, Barbeau G, Noël B, Rouleau J, Boudreault JR, Bertrand OF. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.. Am J Cardiol 2007; 100(4):640-5.
- Déry JP, DeLarochellière R. Time to reperfusion therapy (author reply).. CMAJ 2007; 176(10):1460-1.
- Garceau P, Déry JP, Lachance P, Grenier S, Rodés-Cabau J, Barbeau G, Bertrand OF, Gleeton O, Larose E, Nguyen CM, Noël B, Proulx G, Roy L, de Larochellière R. Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute.. Can J Cardiol 2007; 23(0):53-57B.
- Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.. Circulation 2008; 118(23):2374-81.
- Lachance P, Déry JP, Rodés-Cabau J, Potvin JM, Barbeau G, Bertrand OF, Gleeton O, Larose E, Nguyen CM, Noël B, Proulx G, Roy L, De Larochellière R. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization.. Cardiovasc Revasc Med 2008; 9(4):229-34.
- Bertrand OF, Rodés-Cabau J, Larose E, Nguyen CM, Déry JP, Proulx G, Roy L, Poirier P, Costerousse O, De Larochellière R. Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: a sub-analysis of the EASY trial.. Int J Cardiol 2008; 0(0):Epub.
- Lachance P, Déry JP, Beaudoin J, Barbeau GE, Noël B, Bertrand OF, Rodés-Cabau J, Nguyen CM, Proulx G, Gleeton O, Larose E, Roy L, Delarochelliére R. ECG-guided immediate intervention at the time of primary PCI to reduce door-to-balloon time in ST-elevation myocardial infarction patients.. J Invasive Cardiol 2008; 20(11):623-6.
- Courtis J, Rodés-Cabau J, Larose E, Potvin JM, Déry JP, Larochellière RD, Côté M, Cousterousse O, Nguyen CM, Proulx G, Rinfret S, Bertrand OF. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.. Am J Cardiol 2009; 103(7):943-9.
- Elbarasi E, Goodman SG, Yan RT, Welsh RC, Kornder J, Wong GC, Déry JP, Anderson F, Gore JM, Fox KA, Yan AT; Canadian Acute Coronary Syndrome Registries I and II (ACS I and ACS II); Canadian Global Registry of Acute Coronary Events (GRACE/expanded-GRACE) Investigators.. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.. Am Heart J 2010; 159(1):40-6.
- Bertrand OF, Rodés-Cabau J, Larose E, Nguyen CM, Déry JP, Proulx G, Roy L, Poirier P, Costerousse O, De Larochellière R. Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial.. Int J Cardiol 2009; 136(2):165-70.
- Gilbert P, Bourgault C, Couture C, Déry JP, Bergeron S, Sénéchal M. Splenic infarction associated with a mobile aortic valve lesion: a case report and review of the literature.. Can J Cardiol 2009; 25(6):e215-6.
- Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Bagur R, Proulx G, Nguyen CM, Côté M, Landcop MC, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Courtis J, Dagenais GR, Després JP, DeLarochellière R. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.. Circulation 2009; 120(20):1978-86.
- Larose E, Tizon-Marcos H, Rodés-Cabau J, Rinfret S, Déry JP, Nguyen CM, Gleeton O, Boudreault JR, Roy L, Noël B, Proulx G, Rouleau J, Barbeau G, De Larochellière R, Bertrand OF.. Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection.. Catheter Cardiovasc Interv 2010; 76(4):461-70.
- Bertrand OF, Larose E, Rodés-Cabau J, Rinfret S, Déry JP, Bagur R, Gleeton O, Nguyen CM, Proulx G, De Larochellière R, Poirier P, Costerousse O, Roy L.. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.. Am J Cardiol 2010; 106(2):155-61.
- Beaudoin J, Dery JP, Lachance P, Bertrand OF, Larose E, Rodés-Cabau J, Noël B, Barbeau G, Proulx G, Nguyen C, Roy L, Gleeton O, Rinfret S, Delarochellière R. Impact of thrombus aspiration on angiographic and clinical outcomes in patients with ST-elevation myocardial infarction.. Cardiovasc Revasc Med 2010; 11(4):218-22.
- Larose E, Rodés-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM, Déry JP, Gleeton O, Roy L, Noël B, Barbeau G, Rouleau J, Boudreault JR, Amyot M, De Larochellière R, Bertrand OF. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction: Traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance.. J Am Coll Cardiol 2010; 55(22):2459-69.
- Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Gaudreault V, Proulx G, Barbeau G, Déry JP, Gleeton O, Manh-Nguyen C, Noël B, Roy L, Costerousse O, De Larochellière R (EArly Discharge after Transradial Stenting of CoronarY Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators). Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.. Am J Cardiol 2010; 105(11):1520-7.
- Tizón-Marcos H, Bagur R, Bilodeau S, Larose E, Dagenais F, Déry JP. Left main mycotic aneurysm causing myocardial infarction.. Can J Cardiol 2010; 26(7):e276-7.
- El-Rayes M, Schampaert E, Tardif JC, Eisenberg MJ, Afilalo M, Kouz S, Lauzon C, Harvey R, Nguyen M, Kouz R, Dery JP, Mansour S, Van Kieu AM, Rinfret S, Huynh T. Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry.. Can J Cardiol 2010; 26(8):431-6.
- Ong G, Bagur R, Barbeau G, Couture C, Trahan S, Déry JP. Severe aortic regurgitation after transradial percutaneous coronary intervention.. Circ Cardiovasc Interv 2011; 4(2):e8-e11.
- Bertrand OF, Larose E, Costerousse O, Mongrain R, Rodés-Cabau J, Déry JP, Nguyen CM, Barbeau G, Gleeton O, Proulx G, De Larochellière R, Noël B, Roy L. Effects of aspiration thrombectomy on necrosis size and ejection fraction after transradial percutaneous coronary intervention in acute ST-elevation myocardial infarction.. Catheter Cardiovasc Interv 2011; 77(4):475-82.
- Paradis JM, Bertrand OF, Delarochellière R, Déry JP, Larose E, Rodés-Cabau J, Rinfret S, Bélisle P, Joseph L. Response to letter regarding article, "drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a bayesian meta-analysis".. Circ Cardiovasc Interv 2011; 4(2):e15.
- Rodés-Cabau J, Gutiérrez M, Courtis J, Larose É, Déry JP, Côté M, Nguyen CM, Gleeton O, Proulx G, Roy L, Noël B, Barbeau G, De Larochellière R, Rinfret S, F Bertrand OF. Importance of Diffuse Atherosclerosis in the Functional Evaluation of Coronary Stenosis in the Proximal-Mid Segment of a Coronary Artery by Myocardial Fractional Flow Reserve Measurements.. Am J Cardiol 2011; 108(4):483-90.
- Kouz R, Kouz S, Schampaert E, Rinfret S, Tardif JC, Nguyen M, Eisenberg M, Harvey R, Afilalo M, Lauzon C, Dery JP, Mansour S, Huynh T. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies.. Int J Cardiol 2011; 153(3):249-55.
- Singh SM, Goodman SG, Yan RT, Dery JP, Wong GC, Gallo R, Grondin FR, Lai K, Lopez-Sendon J, Fox KA, Yan AT, . Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.. Am J Cardiol 2012; 109(3):332-6.
- Déry JP. Controlling lipids after acute coronary syndromes: What is the best strategy?. Clin Lipidol 2011; 6(3):253-5.
- Bataille Y, Déry JP, Larose E, Abdelaal E, Machaalany J, Rodés-Cabau J, Rinfret S, Déry U, Costerousse O, Roy L, Bertrand OF. Incidence and clinical impact of concurrent chronic total occlusion according to gender in ST-Elevation myocardial infarction.. Catheter Cardiovasc Interv 2013; 82(1):19-26.
- Bataille Y, Déry JP, Larose É, Déry U, Costerousse O, Rodés-Cabau J, Gleeton O, Proulx G, Abdelaal E, Machaalany J, Nguyen CM, Noël B, Bertrand OF. Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction.. Am Heart J 2012; 164(4):509-15.
- MacHaalany J, Abdelaal E, Bataille Y, Plourde G, Duranleau-Gagnon P, Larose É, Déry JP, Barbeau G, Rinfret S, Rodés-Cabau J, De Larochellière R, Roy L, Costerousse O, Bertrand OF. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention.. Am J Cardiol 2012; 110(12):1742-8.
- Bataille Y, Déry JP, Larose E, Déry U, Costerousse O, Rodés-Cabau J, Rinfret S, De Larochellière R, Abdelaal E, Machaalany J, Barbeau G, Roy L, Bertrand OF. Prevalence, predictors and clinical impact of unique and multiple chronic total occlusion in non-infarct-related artery in patients presenting with ST-elevation myocardial infarction.. Heart 2012; 98(23):1732-7.
- Reny JL, Combescure C, Daali Y, Fontana P; PON1 Meta-Analysis Group. Aradi D, Combescure C, Daali Y, Delaney J, Déry JP, Fontana P, Gurbel P, Lewis J, Reny JL, Sibbing D, Taubert D, Trenk D. Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.. J Thromb Haemost 2012; 10(7):1242-1251.
- Bernat I, Abdelaal E, Plourde G, Bataille Y, Cech J, Pesek J, Koza J, Jirous S, Machaalany J, Déry JP, Costerousse O, Rokyta R, Bertrand OF. Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock.. Am Heart J 2013; 165(3):338-43.
- Plourde G, Abdelaal E, Bataille Y, Machaalany J, Déry JP, Déry U, Larose E, De Larochellière R, Gleeton O, Barbeau G, Roy L, Costerousse O, Bertrand OF. Effect on Door-to-Balloon Time of Immediate Transradial Percutaneous Coronary Intervention on Culprit Lesion in ST-Elevation Myocardial Infarction Compared to Diagnostic Angiography Followed by Primary Percutaneous Coronary Intervention.. Am J Cardiol 2013; 111(6):836-40.
- Rinfret S, Rodés-Cabau J, Bagur R, Déry JP, Dorais M, Larose E, Barbeau G, Gleeton O, Nguyen CM, Noël B, Proulx G, Roy L, Taillon I, De Larochellière R, Bertrand OF. Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation.. Heart 2013; 99(8):562-9.
- FREEDOM Trial Investigators (incluant Métras J, Larose É, Baillot R, Barbeau G, Bertrand OF, Déry JP, Doyle, Gleeton O, Nguyen CM, Noël B, Proulx G, Raby K, Rinfret S et Roy L du CRIUCPQ). Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367(25):2375-84.
- Huynh T, Kouz S, Yan A, Danchin N, Loughlin JO, Schampaert E, Yan R, Rinfret S, Tardif JC, Eisenberg MJ, Afilalo M, Chong A, Dery JP, Nguyen M, Lauzon C, Mansour S, Ko DT, Tu JV, Goodman S.. Canada Acute Coronary Syndrome Risk Score: A new risk score for early prognostication in acute coronary syndromes.. Am Heart J 2013; 166(1):58-63.
- Bataille Y, Plourde G, Machaalany J, Abdelaal E, Déry JP, Larose E, Déry U, Noël B, Barbeau G, Roy L, Costerousse O, Bertrand OF.. Interaction of Chronic Total Occlusion and Chronic Kidney Disease in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction.. Am J Cardiol 2013; 112(2):194-9.
- Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka GD, Held C, Nicolau JC, Storey RF, Ruzyllo W, Huber K, Sinnaeve P, Weiss AT, Déry JP, Moliterno DJ, de Werf FV, Aylward PE, White HD, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW.. Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery: Subgroup Analysis from the TRACER Trial.. J Am Coll Cardiol 2014; 63(11):1048-57.
- Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Urena M, Jerez M, Nombela-Franco L, Ribeiro HB, Allende R, Proulx G, Nguyen CM, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Côté M, Després JP, Dagenais GR, DeLarochellière R. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial.. Can J Cardiol 2014; 30(1):138-45.
- Abdelaal E, Plourde G, Machaalany J, Arsenault J, Rimac G, Déry JP, Barbeau G, Larose E, De Larochellière R, Nguyen CM, Allende R, Ribeiro H, Costerousse O, Mongrain R, Bertrand OF. Effectiveness of Low Rate Fluoroscopy at Reducing Operator and Patient Radiation Dose During Transradial Coronary Angiography and Interventions.. JACC Cardiovasc Interv 2014; 7(5):567-74.
- MacHaalany J, Bertrand OF, O'Connor K, Abdelaal E, Voisine P, Larose É, Charbonneau É, Costerousse O, Déry JP, Sénéchal M. Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation.. Cardiovasc Ultrasound 2014; 12(0):14.
- Storey RF, Kotha J, Smyth S, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.. Thromb Haemost 2014; 111(5):883-91.
- Gandhi S, Zile B, Tan MK, Saranu J, Bucci C, Yan AT, Robertson P, Quantz MA, Letovsky E, Tanguay JF, Déry JP, Fitchett D, Madan M, Cantor WJ, Heffernan M, Natarajan MK, Wong GC, Welsh RC, Goodman SG; Canadian ACS Reflective Group.. Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective.. Can J Cardiol 2014; 30(12):1725-31.
- Wang JY, Goodman SG, Saltzman I, Wong GC, Huynh T, Dery JP, Leiter LA, Bhatt DL, Welsh RC, Spencer FA, Fox KA, Yan AT. Cardiovascular Risk Factors and In-Hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events.. Can J Cardiol 2015; 31(12):1455-61.
- Déry JP, Mahaffey KW, Tricoci P, White HD, Podder M, Westerhout CM, Moliterno DJ, Harrington RA, Chen E, Strony J, Van de Werf F, Ziada KM, Held C, Aylward PE, Armstrong PW, Rao SV. Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.. Catheter Cardiovasc Interv 2015; 0(0):Epub.
- Harvey A, Modak A, Déry U, Roy M, Rinfret S, Bertrand OF, Larose É, Rodés-Cabau J, Barbeau G, Gleeton O, Nguyen CM, Proulx G, Noël B, Roy L, Paradis JM, De Larochellière R, Déry JP. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.. J Breath Res 2016; 10(1):017104.
- Abdelaal E, MacHaalany J, Plourde G, Barria Perez A, Bouchard MP, Roy M, Déry JP, Déry U, Barbeau G, Larose É, Gleeton O, Noël B, Rodés-Cabau J, Roy L, Costerousse O, Bertrand OF. Prediction and impact of failure of transradial approach for primary percutaneous coronary intervention.. Heart 2016; 102(12):919-25.
- Bagai A, Wang TY, Goodman SG, Fisher HN, Welsh RC, Dery JP, Zhang X, Zhu YE, Cheema AN, Dehghani P, Kassam SA, Ducas J, Brass N, Kim HH, Fung A, Schampaert E, Quraishi AU, Mehta SR. Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy.. Int J Cardiol 2017; 228(0):459-464.
- Déry JP, Mehta SR, Fisher HN, Zhang X, Zhu YE, Welsh RC, Lavi S, Cieza T, Henderson MA, Lutchmedial S, Siega AJ, Cheema AN, Wong BY, Kokis A, Dehghani P, Goodman SG. Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).. Am Heart J 2016; 181(0):26-34.
- Sra S, Tan MK, Mehta SR, Fisher HN, Déry JP, Welsh RC, Eisenberg MJ, Overgaard CB, Rose BF, Siega AJ, Cheema AN, Wong BY, Henderson MA, Lutchmedial S, Lavi S, Goodman SG, Yan AT. Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.. Am Heart J 2016; 180(0):82-9.
- Déry JP, Mahaffey KW, Tricoci P, White HD, Podder M, Westerhout CM, Moliterno DJ, Harrington RA, Chen E, Strony J, Van de Werf F, Ziada KM, Held C, Aylward PE, Armstrong PW, Rao SV. Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.. Catheter Cardiovasc Interv 2016; 88(2):163-73.
- Barria Perez AE, Costerousse O, Cieza T, Barbeau G, Déry JP, Maes F, Rimac G, Plourde G, Poirier Y, Carrier MA, Bertrand OF. Feasibility and Safety of Early Repeat Transradial Access Within 30 Days of Previous Coronary Angiography and Intervention.. Am J Cardiol 2017; 120(8):1267-71.
- Russo JJ, Goodman SG, Bagai A, Déry JP, Tan MK, Fisher HN, Zhang X, Zhu YE, Welsh RC, Siega AD, Kokis A, Wong BYL, Henderson M, Lutchmedial S, Lavi S, Mehta SR, Yan AT. Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study.. Eur Heart J Qual Care Clin Outcomes 2017; 3(4):303-311.
- Huynh T, Montigny M, Iftikhar U, Gagnon R, Eisenberg M, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Déry JP, Harvey R, De Larochellière R, Cantin B, Schampaert E, Tardif JC. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study).. Am J Cardiol 2018; 121(8):897-902.
- Maes F, Costerousse O, Cieza T, Henry M, Déry JP, Barbeau G, De Larochellière R, Paradis JM, Larose E, Nguyen CM, Pirlet C, Mongrain R, Bertrand OF. Transradial experience with bioresorbable vascular scaffolds: A case-matched study with metallic drug-eluting stents.. Cardiovasc Revasc Med 2018; 19(6):700-704.
- Bergmeijer TO, Reny JL, Pakyz RE, Gong L, Lewis JP, Kim EY, Aradi D, Fernandez-Cadenas I, Horenstein RB, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Déry JP, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Simon T, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Hulot JS, Mitchell BD, Schwab M, Ritchie MD, Klein TE, Shuldiner AR; ICPC Investigators.. Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). Am Heart J 2018; 198(0):152-159.
- Bertrand OF, Larose E, Bagur R, Maes F, Gaudreault V, Noël B, Barbeau G, Déry JP, Pirlet C, Costerousse O; Early Discharge After Transradial Stenting of Coronary Arteries in Acute Myocardial Infarction (EASY-RESCUE) Percutaneous Coronary Intervention (PCI) Study Investigators2.. A Randomized Double-Blind Placebo-Controlled Study Comparing Intracoronary Versus Intravenous Abciximab in Patients With ST-Elevation Myocardial Infarction Undergoing Transradial Rescue Percutaneous Coronary Intervention After Failed Thrombolysis.. Am J Cardiol 2018; 122(1):47-53.
- Abellas-Sequeiros RA, Benezet J, Agarrado Luna A, Oneto Otero J, Déry JP, Cieza T, De Larochellière R, Duocastella L, Gomez A, Molina M, Asmarats L, Pelletier-Beaumont E, Puri R, Rodés-Cabau J.. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon.. Coron Artery Dis 2018; 29(6):477-481.
- Ghosh-Swaby OR, Tan M, Bagai A, Yan AT, Goodman SG, Mehta SR, Fisher HN, Cohen EA, Huynh T, Cantor WJ, Le May MR, Déry JP, Welsh RC, Udell JA.. Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT).. Clin Cardiol 2018; 41(3):285-92.
- Couture EL, Farand P, Nguyen M, Allard C, Wells GA, Mansour S, Rinfret S, Afilalo J, Eisenberg M, Montigny M, Kouz S, Afilalo M, Lauzon C, Dery JP, L'Allier P, Schampaert E, Tardif JC, Huynh T.. Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians.. Catheter Cardiovasc Interv 2018; 92(7):E441-E448.
- Huynh T, Lecca P, Montigny M, Gagnon R, Eisenberg MJ, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Dery JP, Harvey R, Schampaert E, Tardif JC. Ten-Year Statin Adherence in Survivors of ST-Segment Elevation Myocardial Infarction.. J Popul Ther Clin Pharmacol 2018; 25(2):e63-e77.
- Verma SS, Bergmeijer TO, Gong L, Reny JL, Lewis JP, Mitchell BD, Alexopoulos D, Aradi D, Altman RB, Bliden K, Bradford Y, Campo G, Chang K, Cleator JH, Déry JP, Dridi NP, Fernandez-Cadenas I, Fontana P, Gawaz M, Geisler T, Gensini GF, Giusti B, Gurbel PA, Hochholzer W, Holmvang L, Kim EY, Kim HS, Marcucci R, Montaner J, Backman JD, Pakyz RE, Roden DM, Schaeffeler E, Schwab M, Shin JG, Siller-Matula JM, Ten Berg JM, Trenk D, Valgimigli M, Wallace J, Wen MS, Kubo M, Lee MTM, Whaley R, Winter S, Klein TE, Shuldiner AR, Ritchie MD. Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium.. Clin Pharmacol Ther 2020; 108(5):1067-1077.
- Lewis JP, Backman JD, Reny JL, Bergmeijer TO, Mitchell BD, Ritchie MD, Déry JP, Pakyz RE, Gong L, Ryan K, Kim EY, Aradi D, Fernandez-Cadenas I, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Gawaz M, Bliden KP, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Schwab M, Klein TE, Shuldiner AR. Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients.. Eur Heart J Cardiovasc Pharmacother 2020; 6(4):203-210.
- d'Entremont MA, Wee CC, Nguyen M, Couture ÉL, Lemaire-Paquette S, Kouz S, Afilalo M, Rinfret S, Schampaert E, Mansour S, Montigny M, Eisenberg M, Lauzon C, Déry JP, L'Allier P, Tardif JC, Huynh T. Racial Disparities in Acute Coronary Syndrome Management Within a Universal Healthcare Context: Insights From the AMI-OPTIMA Trial.. CJC Open 2021; 3(12):S28-S35.
- Valle FH, Goodman SG, Tan M, Ha A, Mansour S, Welsh RC, Yan AT, Bainey KR, Rinfret S, Potter BJ, Khan R, Simkus G, Natarajan MK, Schwalm JD, Daneault B, Eisenberg MJ, Abunassar J, Har B, Gregoire J, Tanguay JF, Overgaard CB, Dery JP, De Larochelliere R, Paradis JM, Madan M, Elbarouni B, So DYF, Quraishi AU, Bagai A. Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.. CJC Open 2021; 3(12):1419-1427.
- Verma S, Goodman SG, Tan MK, Daneault B, Lubelsky BJ, Mansour S, Lam AS, Laflamme D, Tymchak WJ, Welsh RC, Rose RC, Chetty RM, Constance CM, Cieza T, Potter BJ, Hartleib MC, Khan R, Choi RF, Keeble W, Dery JP, Shukla D, Chua GL, Bainey KR. Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) study.. Int J Clin Pract 2021; 0(0):e14597.
- Patel A, Goodman SG, Tan M, Suskin N, McKelvie R, Mathew AL, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T, Lavi S, Philipp R, Khan R, Yan AT, Radhakrishnan S, Sedlak T, Brunner N, Kim HH, Cieza T, Kassam S, Fordyce CB, Heffernan M, Jedrzkiewicz S, Madan M, Ahmed S, Barry C, Dery JP, Bagai A. Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study.. Clin Cardiol 2021; 44(6):839-847.
- Arbel Y, Patel AD, Goodman SG, Tan MK, Suskin N, McKelvie RS, Mathew AL, Ahmed F, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T, Lavi S, Khan R, Yan AT, Fordyce CB, Heffernan M, Jedrzkiewicz S, Madan M, Ahmed S, Barry C, Dery JP, Bagai A. Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study.. CJC Open 2021; 3(12):1463-1470.
- Graham CA, Tan MK, Chew DP, Gale CP, Fox KAA, Bagai A, Henderson MA, Quraishi AUR, Déry JP, Cheema AN, Fisher H, Brieger D, Lutchmedial SR, Lavi S, Wong BYL, Cieza T, Mehta SR, Brass N, Goodman SG, Yan AT. Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT).. Heart Vessels 2022; 37(8):1291-1298.
- Chow JK, Bagai A, Tan MK, Har BJ, Yip AMC, Paniagua M, Elbarouni B, Bainey KR, Paradis JM, Maranda R, Cantor WJ, Eisenberg MJ, Dery JP, Madan M, Cieza T, Matteau A, Roth S, Lavi S, Glanz A, Gao D, Tahiliani R, Welsh RC, Kim HH, Robinson SD, Daneault B, Chong AY, Le May MR, Ahooja V, Gregoire JC, Nadeau PL, Laksman Z, Heilbron B, Yung D, Minhas K, Bourgeois R, Overgaard CB, Bonakdar H, Logsetty G, Lavoie AJ, De LaRochelliere R, Mansour S, Spindler C, Yan AT, Goodman SG. Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF?+?PCI-II program.. J Cardiol 2023; 82(2):153-161.
- Mehta SR, Bainey KR, Cantor WJ, Lordkipanidzé M, Marquis-Gravel G, Robinson SD, Sibbald M, So DY, Wong GC, Abunassar JG, Ackman ML, Bell AD, Cartier R, Douketis JD, Lawler PR, McMurtry MS, Udell JA, van Diepen S, Verma S, Mancini GBJ, Cairns JA, Tanguay JF; members of the Secondary Panel (Déry JP parmi les collaborateurs). 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.. Can J Cardiol 2018; 34(3):214-233.